What’s Going On With Pfizer Stock Today?

Pfizer Inc (NYSE:PFE) shares have a session volume of 1.218 million, with an average volume (100 day) of 44.467 million.

Tuesday, Pfizer reported a Q4 adjusted EPS of $0.10 versus a consensus loss of $(0.22). The company reported fiscal year 2023 adjusted EPS of $1.84, down 72% year-on-year, significantly impacted by one-time events.

The company reported a 41% decline in Q4 sales to $14.25 billion, down from $24.29 billion a year ago, almost in line with the consensus of $14.21 billion.

Fourth-quarter 2023 R&D Expenses decreased 22% Y/Y operationally, driven primarily by lower compensation-related expenses and lower spending in vaccine programs and ongoing rare disease programs.

For 2024, Pfizer expects R&D expenses of $11 billion-$12 billion.

The company discontinued three programs, including:

  • Fosmanogepix (APX001) is a Phase 2 asset for invasive fungal infections. In November, Basilea Pharmaceutica Ltd acquired the rights to fosmanogepix for an upfront payment of $37 million and potential commercial milestone payments of up to $110 million.

  • Basilea assumed all rights and obligations from previous agreements, comprising potential development, regulatory, and commercial milestone payments of up to $396 million.

  • PF-07062119 is a biologic oncologic asset being studied in a Phase 1 trial for advanced/metastatic gastrointestinal cancer.

  • PF-07260437, a biologic Phase 1 asset for metastatic breast cancer.

Pfizer’s Stock Prediction for 2024

Equity research analysts on and off Wall Street typically use earnings growth and fundamental research as a form of valuation and forecasting. But many in trading turn to technical analysis as a way to form predictive models for share price trajectory.

Some investors look to trends to help forecast where they believe a stock could trade at a certain point in the future. Looking at Pfizer, an investor could make an assessment about a stock’s long term prospects using a moving average and trend line. If they believe a stock will remain above the moving average, which many believe is a bullish signal, they can extrapolate that trend into the future using a trend line. For Pfizer, the 200-day moving average sits at $33.77, according to Benzinga Pro, which is above the current price of $27.16. For more on charts and trend lines, see a description here.

Traders believe that when a stock is above its moving average, it is a generally bullish signal, and when it crosses below, it is a more negative signal. Investors could use trend lines to make an educated guess about where a stock could trade at a later date if conditions remain stable.

Price Action: PFE shares are up 0.37% at $27.18 during the premarket session on the last check Thursday.

Photo via Shutterstock

“ACTIVE INVESTORS’ SECRET WEAPON” Supercharge Your Stock Market Game with the #1 “news & everything else” trading tool: Benzinga Pro – Click here to start Your 14-Day Trial Now!

Get the latest stock analysis from Benzinga?

This article What’s Going On With Pfizer Stock Today? originally appeared on Benzinga.com

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

EMEA Tribune is not involved in this news article, it is taken from our partners and or from the News Agencies. Copyright and Credit go to the News Agencies, email [email protected] Follow our WhatsApp verified Channel210520-twitter-verified-cs-70cdee.jpg (1500×750)

Support Independent Journalism with a donation (Paypal, BTC, USDT, ETH)